Novo Nordisk GlucaGen HypoKit: Detached Needles Risk Serious Injury
Novo Nordisk recalls GlucaGen HypoKit insulin kits with detached needles that could cause serious injury during use. Affected lots and expiration dates listed. Stop using immediately.
Stop using this now
Defective delivery system: detached needles on the syringe in the kit.
Contact the company
What happened, in plain English
Novo Nordisk is recalling GlucaGen HypoKit (glucagon injection kits) because the delivery system has detachable needles that could cause serious injury if the kit is used incorrectly. This is a safety risk for people with low blood sugar who need emergency treatment. Read more at govinfonow.com/recall/42452-novo-nordisk-glucagen-hypokit-detached-needles-risk-serious-injury.
Source Summary by GovInfoNow · govinfonow.com/recall/42452-novo-nordisk-glucagen-hypokit-detached-needles-risk-serious-injury · Updated October 9, 2026 · FDA enforcement record: FDA #D-0217-2017
Cite this page
“Novo Nordisk GlucaGen HypoKit: Detached Needles Risk Serious Injury.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42452-novo-nordisk-glucagen-hypokit-detached-needles-risk-serious-injury. Based on FDA recall #D-0217-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0217-2017%22&limit=1).
Why it’s dangerous
The GlucaGen HypoKit contains a defective delivery system where the needles can detach during use. This could lead to serious injury if the user is unable to properly administer the medication when needed in an emergency.
Who’s affected
People with diabetes who use GlucaGen HypoKit for low blood sugar emergencies are most at risk. The recall affects specific lots manufactured by Novo Nordisk in Denmark.
How to tell if you have this one
Check the product label for the lot numbers: FS6X270, FS6X296, FS6X538, FS6X597, FS6X797, or FS6X875. The expiration date is September 30, 2017.
- Brand
Novo Nordisk- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the GlucaGen HypoKit if you have the affected lot numbers listed in the recall.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide and Worldwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0217-2017 (September 8, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0217-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.